NO175208C - Fremgangsmåte for fremstilling av et tilnærmet rent polypeptid - Google Patents

Fremgangsmåte for fremstilling av et tilnærmet rent polypeptid

Info

Publication number
NO175208C
NO175208C NO904251A NO904251A NO175208C NO 175208 C NO175208 C NO 175208C NO 904251 A NO904251 A NO 904251A NO 904251 A NO904251 A NO 904251A NO 175208 C NO175208 C NO 175208C
Authority
NO
Norway
Prior art keywords
polypeptides
preparation
polypeptide
salts
cells
Prior art date
Application number
NO904251A
Other languages
English (en)
Norwegian (no)
Other versions
NO904251L (no
NO904251D0 (no
NO175208B (de
Inventor
Douglas Phillips
Nicholas Alex Saccomano
Robert Alfred Volkmann
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Publication of NO904251D0 publication Critical patent/NO904251D0/no
Publication of NO904251L publication Critical patent/NO904251L/no
Publication of NO175208B publication Critical patent/NO175208B/no
Publication of NO175208C publication Critical patent/NO175208C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO904251A 1989-09-29 1990-09-28 Fremgangsmåte for fremstilling av et tilnærmet rent polypeptid NO175208C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/415,139 US5122596A (en) 1989-09-29 1989-09-29 Polypeptides useful as blockers of calcium channels

Publications (4)

Publication Number Publication Date
NO904251D0 NO904251D0 (no) 1990-09-28
NO904251L NO904251L (no) 1991-04-02
NO175208B NO175208B (de) 1994-06-06
NO175208C true NO175208C (no) 1994-09-14

Family

ID=23644517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904251A NO175208C (no) 1989-09-29 1990-09-28 Fremgangsmåte for fremstilling av et tilnærmet rent polypeptid

Country Status (27)

Country Link
US (1) US5122596A (de)
EP (1) EP0425096B1 (de)
JP (1) JPH0692440B2 (de)
KR (1) KR930007435B1 (de)
CN (1) CN1033976C (de)
AT (1) ATE103611T1 (de)
AU (1) AU626203B2 (de)
CA (1) CA2026418C (de)
CZ (1) CZ283651B6 (de)
DD (1) DD297652A5 (de)
DE (1) DE69007739T2 (de)
DK (1) DK0425096T3 (de)
EG (1) EG19316A (de)
ES (1) ES2053118T3 (de)
FI (1) FI96865C (de)
HU (1) HU208705B (de)
IE (1) IE64218B1 (de)
IL (1) IL95765A (de)
MY (1) MY106832A (de)
NO (1) NO175208C (de)
NZ (1) NZ235496A (de)
PH (1) PH27403A (de)
PL (1) PL164541B1 (de)
PT (1) PT95424B (de)
RU (1) RU2026866C1 (de)
YU (1) YU184490A (de)
ZA (1) ZA907782B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US5677288A (en) * 1991-05-15 1997-10-14 Cypros Pharmaceutical Corporation Use of aminoglycosides to protect against excitotoxic neuron damage
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
GB9208110D0 (en) * 1992-04-13 1992-05-27 Isis Innovation Assay for antibodies that bind calcium channels
WO1994002511A1 (en) * 1992-07-27 1994-02-03 Pfizer Inc. Calcium channel blocking polypeptide from agelenopsis aperta
WO1994015960A1 (en) * 1993-01-07 1994-07-21 Eisai Co., Ltd. Peptide with glutamate liberation inhibitor and calcium channel inhibitor activities
ES2075796B1 (es) * 1993-08-17 1996-03-01 Pfizer Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio
US5756462A (en) * 1994-01-19 1998-05-26 Pfizer Inc. Pore forming peptides from Geolycosa riogrande
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
US5756663A (en) * 1996-01-03 1998-05-26 Zeneca Limited Antiarrhythmic peptide from venom of spider Grammostola spatulata
WO1998036743A1 (en) * 1997-02-21 1998-08-27 Cypros Pharmaceutical Corporation Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels
JP2006056805A (ja) * 2004-08-18 2006-03-02 Senmi Ekisu Co Ltd カルシウムチャンネル阻害剤
US8299211B2 (en) * 2005-09-30 2012-10-30 The Board Of Trustees Of The University Of Illinois Peptides and regulation of calcium channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
IL92819A0 (en) * 1988-12-23 1990-09-17 Merrell Dow Pharma Polypeptides isolated from the venom of the spider hololena curta
DD298412A5 (de) * 1989-04-28 1992-02-20 ������@���Kk�� Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele

Also Published As

Publication number Publication date
PT95424A (pt) 1991-05-22
IE903491A1 (en) 1991-04-10
HUT55036A (en) 1991-04-29
FI96865B (fi) 1996-05-31
NO904251L (no) 1991-04-02
ZA907782B (en) 1992-05-27
EP0425096A1 (de) 1991-05-02
CZ470790A3 (cs) 1998-02-18
RU2026866C1 (ru) 1995-01-20
DK0425096T3 (da) 1994-05-02
PH27403A (en) 1993-06-21
PL287113A1 (en) 1991-09-09
ATE103611T1 (de) 1994-04-15
IL95765A (en) 1995-07-31
NZ235496A (en) 1991-12-23
FI96865C (fi) 1996-09-10
HU906267D0 (en) 1991-03-28
AU626203B2 (en) 1992-07-23
PL164541B1 (pl) 1994-08-31
AU6366090A (en) 1991-04-11
PT95424B (pt) 1998-06-30
DE69007739D1 (de) 1994-05-05
NO904251D0 (no) 1990-09-28
YU184490A (sh) 1993-05-28
DE69007739T2 (de) 1994-07-07
JPH0692440B2 (ja) 1994-11-16
EP0425096B1 (de) 1994-03-30
US5122596A (en) 1992-06-16
NO175208B (de) 1994-06-06
FI904789A0 (fi) 1990-09-28
CZ283651B6 (cs) 1998-05-13
JPH03120299A (ja) 1991-05-22
IL95765A0 (en) 1991-06-30
EG19316A (en) 1994-12-30
CN1051182A (zh) 1991-05-08
CA2026418A1 (en) 1991-03-30
DD297652A5 (de) 1992-01-16
CA2026418C (en) 1996-09-24
ES2053118T3 (es) 1994-07-16
KR910006326A (ko) 1991-04-29
MY106832A (en) 1995-07-31
HU208705B (en) 1993-12-28
CN1033976C (zh) 1997-02-05
IE64218B1 (en) 1995-07-26
KR930007435B1 (ko) 1993-08-10

Similar Documents

Publication Publication Date Title
HU902610D0 (en) Process for the preparation of polyamines and polypeptides and pharmaceutical compositions containing them
NO175208C (no) Fremgangsmåte for fremstilling av et tilnærmet rent polypeptid
MY104588A (en) Polyamines useful as antagonists of excitatory amino acid neurotransmitters.
RU95105340A (ru) Полипептид из agelenopsis aperta, блокирующий кальциевые каналы и способ лечения заболеваний у млекопитающих

Legal Events

Date Code Title Description
MK1K Patent expired